BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6263540)

  • 1. [Use of SQ 14225 in the treatment of essential arterial hypertension].
    Degli Esposti E; Chiarini C; Fusaroli M; Masi A; Santoro A; Sturani A; Zuccalà A; Zucchelli P
    Clin Ter; 1981 Apr; 97(2):153-63. PubMed ID: 6263540
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of angiotensin I to II converting enzyme inhibitor S.Q. 14225 (captopril), in moderate essential hypertension.
    Ryan E; Muldowney FP
    Ir Med J; 1983 Apr; 76(4):175, 177-8. PubMed ID: 6345457
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of captopril (SQ 14225) with hydrochlorothiazide in the treatment of essential hypertension.
    Aberg H; Frithz G; Mörlin C
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):368-71. PubMed ID: 7030977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experience with a new antihypertensive drug (captopril SQ 14.225), an oral inhibitor of converting enzyme].
    Santucci A; Aguglia F; Ficara C
    Clin Ter; 1981 Apr; 97(1):43-58. PubMed ID: 6269793
    [No Abstract]   [Full Text] [Related]  

  • 5. Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertension.
    Bénétos A; Laflèche A; Asmar R; Gautier S; Safar A; Safar ME
    J Hum Hypertens; 1996 Feb; 10(2):77-82. PubMed ID: 8867559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of mild and moderate arterial hypertension with low doses of captopril].
    Alves Filho G; Santos TC; Carvalho OM; Guariento ME; Rizzalitti F; Rocha JC
    Arq Bras Cardiol; 1984 May; 42(5):377-80. PubMed ID: 6391438
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of captopril in essential hypertension (author's transl)].
    Mimran A; Targhetta R; Laroche B
    Nouv Presse Med; 1981 Apr; 10(19):1579-82. PubMed ID: 7025849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of low doses of captopril, alone or combined with diuretics in the treatment of mild or moderate hypertension].
    Castilho F; Faria Neto A; Santos Neto FB; Assad JE; Levigard RM
    Arq Bras Cardiol; 1984 Oct; 43(4):283-6. PubMed ID: 6399202
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy and safety of captopril in low doses, alone or combined with diuretics, in the treatment of mild or moderate arterial hypertension].
    Dias GC
    Arq Bras Cardiol; 1984 Aug; 43(2):135-7. PubMed ID: 6398043
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
    Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
    Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute inhibition of angiotensin-converting enzyme by captopril. Hemodynamic and biochemical aspects in normotension and essential hypertension].
    Stanek B; Templ H; Pohanka E; Silberbauer K
    Acta Med Austriaca; 1982; 9(5-6):175-80. PubMed ID: 6299046
    [No Abstract]   [Full Text] [Related]  

  • 14. [Captopril in mild or moderate systemic arterial hypertension].
    Spritzer N; Wolmeister H; Spritzer TS; Maciel R
    Arq Bras Cardiol; 1984 Jun; 42(6):447-50. PubMed ID: 6393923
    [No Abstract]   [Full Text] [Related]  

  • 15. Usefulness of orally active angiotensin I converting enzyme inhibitor (SQ 14,225) in the treatment of malignant hypertension.
    Abe I; Kawasaki T; Ueno M; Kawano Y; Uezono K; Ogata M; Kawazoe N; Omae T; Fukiyama K
    Fukuoka Igaku Zasshi; 1980 Mar; 71(3):157-66. PubMed ID: 6247259
    [No Abstract]   [Full Text] [Related]  

  • 16. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antihypertensive effect of captopril in patients with mild or moderate systemic arterial hypertension].
    Savioli RM; Lima EV; Estrella LA; Puppi EJ; Praxedes JN; Nassif M; Stoeber GH; Del Nero Júnior E
    Arq Bras Cardiol; 1984 Jan; 42(1):67-71. PubMed ID: 6378150
    [No Abstract]   [Full Text] [Related]  

  • 18. Captopril - a genuine innovation.
    Drug Ther Bull; 1982 Feb; 20(4):13-5. PubMed ID: 6277587
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of angiotensin I converting enzyme inhibitor (SQ 14225) on arterial blood pressure].
    Watanabe H
    Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):405-19. PubMed ID: 6750185
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of refractory arterial hypertension with a converting enzyme inhibiting drug (Captopril)].
    Lavezzaro GC; Angelino PF; Gastaldo D; Minelli M; Paccotti P; Angeli A
    Minerva Cardioangiol; 1981 Oct; 29(10):519-25. PubMed ID: 7033830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.